Evgeny A. Semchenko

Gold Coast, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Antimicrobial activity of natural quinone-methide triterpenoids celastrol and pristimerin against pathogenic Neisseria.

Antimicrobial activity of natural quinone-methide triterpenoids celastrol and pristimerin against pathogenic Neisseria.

Journal: Microbiology spectrum
Published: December 30, 2025

Efficacy of the meningococcal vaccine against Neisseria gonorrhoeae: a randomised clinical trial (MenGO).

Efficacy of the meningococcal vaccine against Neisseria gonorrhoeae: a randomised clinical trial (MenGO).

Journal: NPJ vaccines
Published: December 04, 2025

Could Neisseria gonorrhoeae have carcinogenic potential? A critical review of current evidence.

Could Neisseria gonorrhoeae have carcinogenic potential? A critical review of current evidence.

Journal: Critical reviews in microbiology
Published: January 08, 2025

Refinement and optimisation of Neisseria gonorrhoeae NHBA and MetQ vaccine candidates.

Refinement and optimisation of Neisseria gonorrhoeae NHBA and MetQ vaccine candidates.

Journal: Vaccine
Published: July 23, 2024

Bifidobacteria support optimal infant vaccine responses.

Bifidobacteria support optimal infant vaccine responses.

Journal: Nature
Published: November 21, 2023

An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.

An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.

Journal: BMC public health
Published: November 08, 2022

Assessment of Serum Bactericidal and Opsonophagocytic Activity of Antibodies to Gonococcal Vaccine Targets.

Assessment of Serum Bactericidal and Opsonophagocytic Activity of Antibodies to Gonococcal Vaccine Targets.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 16, 2021

Outer membrane vesicle vaccines for Neisseria gonorrhoeae.

Outer membrane vesicle vaccines for Neisseria gonorrhoeae.

Journal: Nature reviews. Urology
Published: October 30, 2021

Self-Inhibitory Peptides Targeting the Neisseria gonorrhoeae MtrCDE Efflux Pump Increase Antibiotic Susceptibility.

Self-Inhibitory Peptides Targeting the Neisseria gonorrhoeae MtrCDE Efflux Pump Increase Antibiotic Susceptibility.

Journal: Antimicrobial agents and chemotherapy
Published: October 11, 2021

The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.

The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.

Journal: mBio
Published: March 24, 2021

The Neisseria gonorrhoeae Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells.

The Neisseria gonorrhoeae Vaccine Candidate NHBA Elicits Antibodies That Are Bactericidal, Opsonophagocytic and That Reduce Gonococcal Adherence to Epithelial Cells.

Journal: Vaccines
Published: April 18, 2020

Role of the Gonococcal Neisserial Heparin Binding Antigen in Microcolony Formation, and Serum Resistance and Adherence to Epithelial Cells.

Role of the Gonococcal Neisserial Heparin Binding Antigen in Microcolony Formation, and Serum Resistance and Adherence to Epithelial Cells.

Journal: The Journal of infectious diseases
Published: October 14, 2019
Showing 1-12 of 27

Last Updated: 09/26/2026